Vitamin E Vitamin E


Survey: Pain Patients Overwhelmingly Prefer Medical Marijuana Over Opioids

A new survey of 2,897 patients who need pain relief found that when given a choice, they prefer medical marijuana over opioids, Ars Technica reports. Since medical marijuana has fewer side effects than opioids, it might help the U.S. to address its opioid epidemic and the resulting deaths that occur, if the federal government were to listen to these patients, the study’s researchers suggested — especially since no marijuana overdose deaths have ever been reported to the Drug Enforcement Administration (DEA).

How many times do we need proof that medical cannabis (cannabidiol, or CBD) is a vastly underutilized therapy before the DEA admits that this substance should NOT be a Schedule 1 controlled substance, which puts it on par with LSD and heroin? CBD has no psychoactive component, meaning it cannot render you "high," so it’s ridiculous for the DEA to hold on to this archaic classification of medical marijuana.

The truth is the human endocannabinoid system — endo meaning "within" — strongly suggests the human organism is actually designed to make good use of the cannabis plant. In other words, the marijuana plant triggers something that's been inside us since the dawn of mankind. The endocannabinoid system exists in other mammals as well, suggesting it is a truly an ancient biological system.

By bringing tissues back into balance, cannabinoids can reduce pain and nerve stimulation causing seizures, and stop muscle spasms. They also help you relax and improve sleep. Additionally, medical marijuana has shown positive effects in treating mood disorders, degenerative neurological disorders, multiple sclerosis, Parkinson’s disease and post-traumatic stress disorder (PTSD). It even has a beneficial influence on the aging brain. To put it bluntly, and pun intended, it’s high time for the DEA to loosen its grip on this medical miracle.
Click Here and be the first to comment on this article
Post your comment